Charles Schwab Investment Management Inc. Has $30.23 Million Stake in Addus HomeCare Co. (NASDAQ:ADUS)

Charles Schwab Investment Management Inc. raised its stake in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 8.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 227,209 shares of the company's stock after acquiring an additional 18,555 shares during the quarter. Charles Schwab Investment Management Inc. owned about 1.25% of Addus HomeCare worth $30,226,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of ADUS. GAMMA Investing LLC increased its holdings in shares of Addus HomeCare by 33.8% during the second quarter. GAMMA Investing LLC now owns 744 shares of the company's stock worth $86,000 after purchasing an additional 188 shares during the period. SG Americas Securities LLC bought a new position in shares of Addus HomeCare during the second quarter worth approximately $842,000. Chatham Capital Group Inc. increased its holdings in shares of Addus HomeCare by 1.2% during the second quarter. Chatham Capital Group Inc. now owns 21,609 shares of the company's stock worth $2,509,000 after purchasing an additional 265 shares during the period. Diversified Trust Co increased its holdings in shares of Addus HomeCare by 9.4% during the second quarter. Diversified Trust Co now owns 2,673 shares of the company's stock worth $310,000 after purchasing an additional 230 shares during the period. Finally, Ellsworth Advisors LLC bought a new position in shares of Addus HomeCare during the second quarter worth approximately $598,000. 95.35% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

ADUS has been the topic of a number of recent analyst reports. StockNews.com cut shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Tuesday. Stephens lifted their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an "overweight" rating in a research note on Wednesday, November 6th. Royal Bank of Canada reissued an "outperform" rating and issued a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. TD Cowen lifted their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a "buy" rating in a research note on Thursday, August 8th. Finally, Oppenheimer lifted their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an "outperform" rating in a research note on Monday, September 23rd. One research analyst has rated the stock with a sell rating, one has given a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $131.63.

Insider Transactions at Addus HomeCare

In other news, Director Esteban Lopez sold 500 shares of the firm's stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the sale, the director now owns 3,366 shares of the company's stock, valued at $429,165. This trade represents a 12.93 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO R Dirk Allison sold 12,500 shares of the firm's stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the sale, the chief executive officer now directly owns 141,897 shares of the company's stock, valued at approximately $17,476,034.52. This trade represents a 8.10 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is currently owned by corporate insiders.

Addus HomeCare Stock Down 2.7 %

ADUS traded down $3.33 during midday trading on Thursday, hitting $120.27. 111,741 shares of the company were exchanged, compared to its average volume of 130,749. The firm's 50 day moving average price is $126.69 and its 200-day moving average price is $123.92. Addus HomeCare Co. has a 1-year low of $85.94 and a 1-year high of $136.12. The firm has a market capitalization of $2.18 billion, a P/E ratio of 28.28, a P/E/G ratio of 2.14 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts' consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. During the same period in the previous year, the firm earned $1.03 earnings per share. The firm's quarterly revenue was up 7.1% on a year-over-year basis. On average, sell-side analysts predict that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.